Collegium Pharmaceutical, Inc
COLL· Nasdaq
COLLCollegium Pharmaceutical, Inc
Filed Mar 18, 2016 · 10-K · 78 days after period end · 0001558370-16-004252
| Metric | Q4 2015 | Q4 2014 |
|---|---|---|
| Net Income | -$9.53M | -$3.47M |
| EPS Diluted | -$0.46 | -$4.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 18, 2016 · 78 d after period end
